Father’s Day Sale: 15% off Sitewide w/code DAD15 (excludes sale items / ends Sun 6/21 at 9pm CST)
ANNIV40 for 40% OFF sitewide (no stacking, no sale items) ANNIV40 for 40% OFF sitewide (no stacking, no sale items) ANNIV40 for 40% OFF sitewide (no stacking, no sale items) ANNIV40 for 40% OFF sitewide (no stacking, no sale items) ANNIV40 for 40% OFF sitewide (no stacking, no sale items)

What Is TB-500?

TB-500 is a synthetic research peptide based on thymosin beta-4, a 43-amino-acid protein that binds actin inside cells. Sellers use the name for two different molecules: a 7-amino-acid piece of the protein, or the whole protein. The whole protein weighs about 4,963 daltons; the piece, about 889.

Renovita Research sells TB-500 10mg (RESEARCH USE ONLY) as a lyophilized vial with the certificate for its lot on the product page. Below, updated 17 November 2026: the two molecules side by side, how to read a certificate of analysis, and the numbers on one real lot.

Key Takeaways

  • TB-500 can mean a 7-amino-acid piece of thymosin beta-4 (about 889 daltons) or the whole 43-amino-acid protein (about 4,963 daltons). The FDA ties the name to the piece; WADA and Healthy Male tie it to thymosin beta-4.
  • 10 mg of the piece holds about 5.6 times as many molecules as 10 mg of the protein, so the two forms are not interchangeable in an experiment.
  • A purity figure cannot tell the two apart. The mass on the lot’s certificate of analysis, measured by LC-MS (liquid chromatography with mass spectrometry), can.
  • The certificate for Renovita Research’s TB-500 10mg lot MYA2605TB10 names the identity as Thymosin Beta-4, and its four labelled ions work out to 4,960.8 to 4,962.6 daltons, the mass of the whole protein.
  • The thymosin beta-4 studies cited here are cell and animal work on the whole protein, covering actin binding, cell movement, wound models in rats and heart models in mice.
  • WADA bans thymosin beta-4 and its derivatives, TB-500 included, under class S2.

Fragment or full-length: what is the difference?

The two molecules sold as TB-500 differ in length, sequence and mass. The fragment, written Ac-LKKTETQ, is 7 amino acids long; full-length thymosin beta-4 is 43.

Full-length thymosin beta-4TB-500 fragment (Ac-LKKTETQ)
Length43 amino acids7 amino acids
SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGESAc-LKKTETQ (residues 17 to 23 of the protein)
Average massabout 4,963 Daabout 889 Da
Molecules in 10 mgabout 2.0 µmolabout 11.2 µmol
SourceUniProt P62328Esposito et al., 2012

The masses and molar amounts are calculated from the listed sequences using standard average residue masses, from Expasy’s table of average amino acid residue masses, plus 42.04 Da for the acetyl group. “Ac-” means the first amino acid carries an acetyl group, as it does in the natural protein.

The fragment comes from a working part of the protein. A Ghent University team that built full-length thymosin beta-4 variants found its actin-binding site has two parts: the first 16 residues, and a six-residue motif at residues 17 to 22, where lysine 18 makes contact with actin (Van Troys et al., EMBO Journal, 1996). Residues 17 to 23 are the stretch Ac-LKKTETQ copies. In 2012 another Ghent team analysed a product sold as TB-500 and identified its content as this acetylated 17 to 23 fragment (Esposito et al., Drug Testing and Analysis, 2012).

Only the FDA pins the name to the fragment. WADA and Healthy Male tie it to thymosin beta-4 without saying which form:

BodyWhat it lists as TB-500Page date
US Food and Drug Administration“Thymosin beta-4, fragment (LKKTETQ), also known as TB-500” (FDA)current as of 22 April 2026
World Anti-Doping Agency“Thymosin-β4 and its derivatives e.g. TB-500” (WADA Prohibited List)2026 list
Healthy Male (Australian Government funded)“a synthetic version of thymosin beta-4” (Healthy Male)updated 24 April 2026

For a lab, the gap shows up twice. Work done with the fragment says nothing certain about the 43-residue protein, and the reverse. And the same weight is a different amount of molecule: a 10 mg vial of the fragment holds about 5.6 times as many molecules as a 10 mg vial of the full-length protein, so any experiment planned in moles changes with the form.

How can you tell which TB-500 is in a vial?

The certificate of analysis (COA) for the vial’s lot answers it, if the certificate carries mass data. A purity figure alone cannot: 99% pure says how clean the sample is, and nothing about which molecule it is.

Four checks, in order:

  1. Identity method. Look for identity confirmed by LC-MS, meaning liquid chromatography paired with a mass spectrometer. That is the test that weighs the molecule.
  2. The mass itself. A mass spectrum lists ions as m/z values with a charge, such as [M+5H]5+. Multiply the m/z by the charge and subtract about 1.007 for each charge, the mass of one proton (NIST CODATA value for the proton mass, 1.007276 u). Results near 4,963 Da point to full-length thymosin beta-4. Results near 889 Da point to the fragment.
  3. Lot number. The lot on the certificate should match the lot on the vial. A certificate with no lot ties to nothing.
  4. Client name and lookup code. The client line shows who ordered the test, the lot number ties it to the vial, and a reference code lets the issuing lab look the report up.

Worked example: reading one TB-500 10mg certificate

The certificate for Renovita Research’s TB-500 10mg lot MYA2605TB10, shown on the TB-500 10mg (RESEARCH USE ONLY) page, was reported on 11 May 2026 by an outside US analytical lab. Here is what it shows against the four checks.

  • Identity (LC-MS): Thymosin Beta-4, confirmed.
  • Purity (HPLC-UV): 99.65%, one main peak on the chromatogram.
  • Net content: reported on the certificate, against 10 mg on the label.
  • Client and lookup: Renovita Research LLC, with an accession number and a search code printed on the certificate.

The mass panel labels four thymosin beta-4 ions; its other peaks are unlabelled. Worked through with the step 2 arithmetic:

Ion on the certificatem/zChargeMass it implies
[M+7H]7+709.974,962.2 Da
[M+6H]6+828.164,962.6 Da
[M+5H]5+993.354,961.5 Da
[M+4H]4+1241.244,960.8 Da

All four land within about 3 Da of 4,963, the mass of the whole 43-residue protein, and far from the 889 Da fragment. The identity line, Thymosin Beta-4, is the certificate’s own wording; the mass column is calculated from the labelled ions using the formula in step 2.

What is thymosin beta-4 studied for?

Inside cells, thymosin beta-4 works as an actin buffer. Actin is the protein cells use to build their internal scaffolding, and thymosin beta-4 holds single actin units (G-actin) in a one-to-one pair so they cannot join into filaments. A 1991 University of Pennsylvania study found that at least half the actin in resting human platelets is unpolymerized, mostly held by this protein (Safer et al., Journal of Biological Chemistry, 1991). A 2001 review from the University of Erlangen-Nuremberg describes it as present in high concentrations in almost every cell, and also found outside cells in blood plasma and wound fluid (Huff et al., 2001).

From that base, researchers have tested it in cell and animal models of tissue repair:

  • Cell movement and wound models. In an NIH study, thymosin beta-4 increased keratinocyte migration two- to threefold in a cell assay, and in a rat full-thickness wound model it increased re-epithelialization by 42% over saline controls at day 4 and by up to 61% at day 7 (Malinda et al., Journal of Investigative Dermatology, 1999).
  • Heart models in mice. A 2004 study found thymosin beta-4 forms a complex with two signalling proteins, PINCH and integrin-linked kinase, and reported that in mice after coronary artery ligation it raised the activity of both in the heart and increased early heart-muscle cell survival (Bock-Marquette et al., Nature, 2004). A 2007 study identified it as essential for coronary vessel development in mouse embryos (Smart et al., Nature, 2007). A 2012 review gathers this work across skin, eye, heart and brain research (Goldstein et al., Expert Opinion on Biological Therapy, 2012).

Each of these papers names thymosin beta-4, the whole protein, as the material studied. Healthy Male notes that thymosin beta-4 was studied in animal and cell experiments, with TB-500 “assumed to behave similarly rather than being independently validated”, and that there are no large, well-controlled human trials showing clear benefit of TB-500 (Healthy Male). The papers cited here describe the 43-residue protein.

How do the FDA and WADA list TB-500?

The FDA lists TB-500 by its fragment form. Its page of bulk drug substances for use in compounding that may present significant safety risks names “Thymosin beta-4, fragment (LKKTETQ), also known as TB-500” and states that FDA “has not identified any human exposure data” for drug products containing it (FDA, content current as of 22 April 2026). WADA’s 2026 Prohibited List bans “Thymosin-β4 and its derivatives e.g. TB-500” at all times under S2.3, growth factors and growth factor modulators (WADA).

Renovita Research sells TB-500 as a laboratory reference material; its terms for that are on its research use only page.

Frequently Asked Questions

What is TB500?

TB500 is a synthetic research peptide based on thymosin beta-4, sold either as the 7-amino-acid fragment Ac-LKKTETQ or as the whole 43-amino-acid protein. TB500 and TB-500 are the same name, written with or without the hyphen.

What does TB-500 do?

TB-500 is a laboratory research material, and what it does depends on which form a vial holds.

Thymosin beta-4, the whole protein, holds single actin units (G-actin), the building blocks of a cell’s internal scaffolding, which ties it to research on how cells change shape and move.

Mutation work by Van Troys and colleagues (EMBO Journal, 1996) placed part of that actin-binding site at residues 17 to 22, inside the stretch the 7-amino-acid fragment copies.

The studies cited in this guide use cell and animal models of the whole protein, and the Australian men’s health body Healthy Male notes there are no large, well-controlled human trials showing clear benefit of TB-500.

What is thymosin beta-4?

Thymosin beta-4 is a 43-amino-acid protein that binds actin inside cells, listed in the UniProt protein database as entry P62328. Its first amino acid carries an acetyl group, and the whole protein weighs about 4,963 daltons. Synthetic thymosin beta-4 is one of the two molecules sold under the name TB-500.

TB-500 vs thymosin beta-4: what is the difference?

TB-500 and thymosin beta-4 are the same molecule only when the vial holds the full-length protein. Thymosin beta-4 is the scientific name of one 43-amino-acid protein. TB-500 can mean that protein or its 7-amino-acid piece from residues 17 to 23, Ac-LKKTETQ, which a 2012 Ghent University analysis identified in a product sold as TB-500 (Esposito et al., Drug Testing and Analysis), and which the FDA names as TB-500. The piece weighs about 889 daltons against about 4,963 for the protein, so 10 mg of the piece holds about 5.6 times as many molecules as 10 mg of the protein.

How do you check which TB-500 a supplier sells?

Open the certificate of analysis for the vial’s lot and look for identity confirmed by LC-MS, with the measured mass. A mass near 4,963 Da means full-length thymosin beta-4; a mass near 889 Da means the fragment. A purity figure such as 99% does not show which molecule it is, and the lot number on the certificate should match the vial.

Is Renovita Research’s TB-500 the fragment or the full-length protein?

The certificate for TB-500 10mg lot MYA2605TB10 names the identity as Thymosin Beta-4 by LC-MS, and its four labelled ions work out to 4,960.8 to 4,962.6 Da. That is within about 3 Da of the whole 43-residue protein and far from the 889 Da fragment. Each mass is the ion’s m/z times its charge, minus about 1.007 per charge.

Where to get a TB-500 vial with its lot certificate

Renovita Research is a Missouri-based company that sells its peptides strictly for laboratory and research use, not for human or animal consumption, and ships to addresses in the United States only, per its shipping policy.

TB-500 10mg (RESEARCH USE ONLY) is one 10 mg lyophilized vial, stored at −20 °C or below, with the lot certificate above on its page.

BPC-157 is the peptide TB-500 is sold with as the “wolverine stack”. Healthy Male describes that combination as claimed to speed healing and reduce inflammation, and states: “There is no evidence of benefits from either peptide in isolation, or together.” The wolverine stack peptide guide covers the pairing, what a 1:1 label means in molecules and how to read the blend’s certificate.

The same 10 mg vials also come in the Dual Peptide Reference Kit (RESEARCH USE ONLY), and the full range is on the peptides shelf.

Shopping Cart

Before You Enter

Renovita Research products are sold strictly for laboratory and research use only. Please confirm the following before continuing.

Scroll to Top